Use of Inflammatory Markers for Early Detection of Bacteraemia in Patients with Febrile Neutropenia

References

• Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730–51.
   Web of Science ®Google Scholar
• Ewig S, Glasmacher A, Ulrich B, Wilhelm K, Schafer H, Nachtsheim KH. Pulmonary infiltrates in neutropenic patients with acute leukaemia during chemotherapy: outcome and prognostic factors. Chest 1998; 114: 444–51.
   PubMed Web of Science ®Google Scholar
• Maschmeyer G, Link H, Hiddemann W, Meyer P, Helmerking M, Eisenmann E, et al. Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study. Cancer 1994; 73: 2296–304.
   Google Scholar
• Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993; 328: 1323–32.
   PubMed Web of Science ®Google Scholar
• Rintala E. Incidence and clinical significance of positive blood cultures in febrile episodes of patients with haematological malignancies. Scand J Infect Dis 1994; 26: 77–84.
   PubMed Web of Science ®Google Scholar
• Engervall PA, Stiernstedt GT, Gunther GC, Bjorkholm MJ. Trimethoprim-sulfamethoxazole plus amikacin as first-line therapy and imipenem/cilastatin as second empirical therapy in febrile neutropenic patients with haematological disorders. J Chemother 1992; 4: 99–106.
   PubMed Web of Science ®Google Scholar
• Sudhoff T, Giagounidis A, Karthaus M. Evaluation of neutropenic fever: value of serum and plasma parameters in clinical practice. Chemotherapy 2000; 46: 77–85.
   Google Scholar
• Holm S. A simple sequentially rejective multiple test procedure. Scand J Statist 1979; 6: 65–70.
   Web of Science ®Google Scholar
• Page EB. Ordered hypotheses for multiple treatments: a significance test for linear ranks. J Am Statist Association 1963; 58: 216–30.
   Google Scholar
• Rose PE, Johnsdon SA, Meakin M, Mackie PH, Stuart J. Serial study of C-reactive protein during infection in leukaemia. J Clin Pathol 1981; 34: 263–6.
   Google Scholar
• Schonbohn H, Schuler M, Kolbe K, Peschel C, Huber C, Bemb W, Aulitzky WE. Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukaemia. Ann Hematol 1995; 71: 161–8.
   Google Scholar
• Antonelli M, Raponi GM, Martino P, Rosa G, Conti G, Jalouk J, Gasparetto A. High IL-6 serum levels are associated with septic shock and mortality in septic patients with severe leukopenia due to haematological malignancies. Scand J Infect Dis 1995; 27: 381–4.
   Google Scholar
• Engervall P, Andersson B, Bjorkholm M. Clinical significance of serum cytokine patterns during start of fever in patients with neutropenia. Br J Haematol 1995; 91: 838–45.
   Google Scholar
• Engervall P, Granstrom M, Andersson B, Bjorkholm M. Monitoring of endotoxin, interleukin-6 and C-reactive protein serum concentrations in neutropenic patients with fever. Eur J Haematol 1995; 54: 226–34.
   PubMed Web of Science ®Google Scholar
• de Bont ES, Vellenga E, Swaanenburg JC, Fidler V, Visser-van Brummen PJ, Kamps WA. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia. Br J Haematol 1999; 107: 375–80.
   Google Scholar
• Lehrnbecher T, Venzon D, de Haas M, Chanock SJ, Kuhl J. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia. Clin Infect Dis 1999; 29: 414–9.
   Google Scholar
• Engel A, Steinbach G, Kern P, Kern WV. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Scand J Infect Dis 1999; 31: 185–9.
   PubMed Web of Science ®Google Scholar
• Ruokonen E, Nousiainen T, Pulkki K, Takala J. Procalcitonin concentrations in patients with neutropenic fever. Eur J Clin Microbiol Infect Dis 1999; 18: 283–5.
   PubMed Web of Science ®Google Scholar
• Giamarellos-Bourboulis EJ, Grecka P, Poulakou G, Anargyrou K, Katsilambros N, Giamarellou H. Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia. Clin Infect Dis 2001; 32: 1718–25.
   Google Scholar
• Arber C, Passweg JR, Fluckiger U, Pless M, Gregor M, Tichelli A, et al. C-reactive protein and fever in neutropenic patients. Scand J Infect Dis 2000; 32: 515–20.
   PubMed Web of Science ®Google Scholar
• Bernard L, Ferriere F, Casassus P, Malas F, Leveque S, Guillevin L, Lortholary O. Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults. Clin Infect Dis 1998; 27: 914–5.
   PubMed Web of Science ®Google Scholar
• Manian FA. A prospective study of daily measurement of C- reactive protein in serum of adults with neutropenia. Clin Infect Dis 1995; 21: 114–21.
   PubMed Web of Science ®Google Scholar
• Katz JA, Mustafa MM, Bash RO, Cash JV, Buchanan GR. Value of C-reactive protein determination in the initial diagnostic evaluation of the febrile, neutropenic child with cancer. Pediatr Infect Dis J 1992; 11: 708–12.
   Google Scholar
• Gendrel D, Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J 2000; 19: 679–87.
   PubMed Web of Science ®Google Scholar
• Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515–8.
   PubMed Web of Science ®Google Scholar
• Brunkhorst FM, Heinz U, Forycki ZF. Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med 1998; 24: 888–9.
   PubMed Web of Science ®Google Scholar
• Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79: 1605–8.
   Google Scholar
• Lyytikainen O, Valtonen V, Anttila VJ, Ruutu P Evaluation of clinical and laboratory findings in leukaemic patients with blood cultures positive for Staphylococcus epidermidis. J Hosp Infect 1998; 38: 27–35.
   PubMed Web of Science ®Google Scholar
• Mattsson E, Verhage L, Rollof J, Fleer A, Verhoef J, van Dijk H. Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6. FEMS Immunol Med Microbiol 1993; 7: 281–7.
   Google Scholar